IP Library Granted Patent US 8,263,364
Granted Patent B2
US 8,263,364 · App. 13/008,303 · Granted Sep 11, 2012

Method of determining the nucleotide sequence of oligonucleotides and DNA molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,364
App. No.
13/008,303
Granted
Sep 11, 2012
Kind
B2
Abstract

The present invention relates to a novel method for analyzing nucleic acid sequences based on real-time detection of DNA polymerase-catalyzed incorporation of each of the four nucleotide bases, supplied individually and serially in a microfluidic system, to a reaction cell containing a template system comprising a DNA fragment of unknown sequence and an oligonucleotide primer. Incorporation of a nucleotide base into the template system can be detected by any of a variety of methods including but not limited to fluorescence and chemiluminescence detection. Alternatively, microcalorimetic detection of the heat generated by the incorporation of a nucleotide into the extending template system using thermopile, thermistor and refractive index measurements can be used to detect extension reactions.

Claims (18)

1. A method of nucleic acid sequencing, the method comprising the steps of: (a) hybridizing a template to a universal primer that comprises a homopolymer region to form a primer/template system; (b) on a solid phase, catalyzing incorporation of a nucleotide to said primer/template system with a polymerase by exposing said primer/template system to said polymerase and one or more types of nucleotides comprising an optically-detectable label, wherein said optically-detectable label is not attached to the 3′ hydroxyl of the sugar moiety of said nucleotide; (c) detecting incorporated nucleotide by the presence of said label; (d) removing said label from said incorporated nucleotide; (e) permitting steps (b) through (d) to occur multiple times so as to determine a nucleic acid sequence based upon said incorporated nucleotides.

2. The method of claim 1 , wherein said template or primer is covalently attached to said solid phase.

3. The method of claim 1 , wherein a single nucleotide type is exposed to said primer/template in step (b).

4. The method of claim 1 , wherein said polymerase is a mutant polymerase.

5. The method of claim 1 , wherein said label is attached to said nucleotide via a chemically-cleavable linker.

6. The method of claim 1 , wherein said label is removed at the completion of each of said multiple times.

7. The method of claim 1 , wherein said nucleotides comprising an optically-detectable label are present in excess concentration relative to said template.

8. The method of claim 1 , wherein said detecting step comprises real-time detection of polymerase-catalyzed incorporation of said incorporated nucleotide.

9. The method of claim 8 , wherein said real-time detection comprises detecting said incorporated nucleotide while an incorporation reaction is occurring.

10. The method of claim 1 , wherein said removing step comprises cleaving a chemically cleavable linker.

11. The method of claim 1 , wherein said template is an unknown sequence.

12. The method of claim 1 , wherein said template is generated via PCR amplification.

13. The method of claim 1 , wherein steps (b) through (d) are repeated to determine an entire sequence of said template.

14. The method of claim 1 , wherein said template is directly attached to said solid phase.

15. The method of claim 1 , wherein said template is indirectly attached to said solid phase.

16. The method of claim 1 , wherein said primer/template system is immobilized such that said primer/template system is individually optically resolvable on said solid phase.

17. The method of claim 1 , wherein said solid phase is in a microfluidic system.

18. The method of claim 1 , wherein excess unincorporated nucleotide is removed prior to detecting said label.

Assignments (4)
TERMINATION AND RELEASE OF NOTICE OF ATTORNEY'S LIEN Recorded Aug 30, 2018
From: BROWN RUDNICK LLP
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 046988/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031159/0626 →
NOTICE OF ATTORNEY'S LIEN Recorded Apr 17, 2012
From: HELICOS BIOSCIENCES CORPORATION
To: BROWN RUDNICK LLP
Reel/Frame 028060/0898 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2011
From: WILLIAMS, PETER; TAYLOR, THOMAS J.; WILLIAMS, DANIEL J. B.; GOULD, IAN; HAYES, MARK A.
To: ARIZONA BOARD OF REGENTS
Reel/Frame 026980/0282 →